TRACY HOOPER: Open Payments
NPI 1619962206 · CHATSWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 45 payments from 16 companies in 2025. Trend: 2023 $990 · 2024 $1,280 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $155 |
| PFIZER INC. | 7 | $145 |
| Novo Nordisk Inc | 9 | $142 |
| ABBVIE INC. | 4 | $100 |
| Lilly USA, LLC | 4 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
Products named: Auvelity, Wegovy, VRAYLAR, PREVNAR 20, ELIQUIS, XIFAXAN, CAPLYTA, Kerendia.
Industry payments across GA — which companies pay providers there.
